Future course of sanctions and flow of Russian gas to Europe could impact up to $120 billion of investment and 29 MMtpa for future U.S. LNG projects WASHINGTON , May 8, 2025 /PRNewswire/ -- The United States, which currently supplies half of Europe's liquefied natural gas (LNG) imports and roughly 15% of the continent's total gas supply, would be disproportionately impacted if current restrictions on Russian gas and LNG were to change, a new S&P Global Commodity Insights study finds. The report, U.S. LNG Exports at Risk: Potential Unwinding of Sanctions on Russian Natural Gas found that, under an "Opening …

image for news Changing Restrictions on Russian Gas to Europe Would Disproportionately Impact US LNG Exports, New S&P Global Commodity Insights Study Finds

Murphy Oil's Q1 Earnings Surpass Estimates, Revenues Miss — Positive

MUR   Zacks Investment Research — May 08, 2025

MUR's first-quarter earnings are better than expected. Production volume in the first quarter are impacted by unplanned downtime and winter storms.

image for news Murphy Oil's Q1 Earnings Surpass Estimates, Revenues Miss

Acadia Q1 Earnings Beat, Nuplazid & Daybue Sales Drive Revenue Growth — Positive

ACAD   Zacks Investment Research — May 08, 2025

ACAD reports encouraging first-quarter results as earnings and revenues beat estimates, driven by year-over-year growth in Nuplazid and Daybue sales.

image for news Acadia Q1 Earnings Beat, Nuplazid & Daybue Sales Drive Revenue Growth

TORM PLC (TRMD) Misses Q1 Earnings Estimates — Negative

TRMD   Zacks Investment Research — May 08, 2025

TORM PLC (TRMD) came out with quarterly earnings of $0.62 per share, missing the Zacks Consensus Estimate of $0.64 per share. This compares to earnings of $2.26 per share a year ago.

image for news TORM PLC (TRMD) Misses Q1 Earnings Estimates

Amazon adds pet prescriptions to its online pharmacy — Positive

AMZN   CNBC — May 08, 2025

Amazon is adding "hundreds of commonly prescribed pet medications" to its online pharmacy in the U.S. Prescriptions are dispensed and delivered by Vetsource, an online pet pharmacy, but are ordered through Amazon's storefront.

image for news Amazon adds pet prescriptions to its online pharmacy

MKS Instruments, Inc. (NASDAQ:MKSI ) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants Paretosh Misra - VP, IR John Lee - President and CEO Ram Mayampurath - EVP, CFO and Treasurer Conference Call Participants Steve Barger - KeyBanc Capital Markets Shane Brett - Morgan Stanley Krish Sankar - TD Cowen Jim Ricchiuti - Needham & Company Michael Mani - Bank of America Securities Matthew Prisco - Cantor Fitzgerald Melissa Weathers - Deutsche Bank Operator Good day, and thank you for standing by. Welcome to the MKS Instruments First Quarter 2025 Earnings Conference Call.

image for news MKS Instruments, Inc. (MKSI) Q1 2025 Earnings Conference Call Transcript

Canadian Natural Resources Limited (NYSE:CNQ ) Q1 2025 Earnings Conference Call May 8, 2025 9:00 AM ET Company Participants Lance Casson - Manager of IR Scott Stauth - President Victor Darel - CFO Conference Call Participants Greg Pardy - RBC Capital Markets Manav Gupta - UBS Financial Dennis Fong - CIBC Capital Markets Menno Hulshoff - TD Securities John Moyle - JP Morgan Neil Mehta - Goldman Sachs Patrick O'Rourke - ATB Capital Markets Operator Good morning. We would like to welcome everyone to Canadian Naturals 2025 First Quarter Earnings Conference call and webcast.

image for news Canadian Natural Resources Limited (CNQ) Q1 2025 Earnings Conference Call Transcript

Intellia Therapeutics, Inc. (NTLA) Q1 2025 Earnings Call Transcript — Neutral

NTLA   Seeking Alpha — May 08, 2025

Intellia Therapeutics, Inc. (NASDAQ:NTLA ) Q1 2025 Results Conference Call May 8, 2025 8:00 AM ET Company Participants Brittany Chaves - Senior Manager of Investor Relations John Leonard - President and Chief Executive Officer David Lebwohl - Chief Medical Officer Ed Dulac - Executive Vice President and Chief Financial Officer Birgit Schultes - Executive Vice President and Chief Scientific Officer Conference Call Participants Gena Wang - Barclays Kostas Biliouris - BMO Capital Markets Luca Issi - RBC Maury Raycroft - Jefferies Mitchell Kapoor - H. C. Wainwright Jay Olson - Oppenheimer Rick Bienkowski - Cantor Fitzgerald Yanan Zhu - Wells …

image for news Intellia Therapeutics, Inc. (NTLA) Q1 2025 Earnings Call Transcript

Start Time: 08:30 January 1, 0000 9:36 AM ET Restaurant Brands International Inc. (NYSE:QSR ) Q1 2025 Earnings Conference Call May 08, 2025, 08:30 AM ET Company Participants Josh Kobza - CEO Sami Siddiqui - CFO Patrick Doyle - Executive Chairman Kendall Peck - Head, IR Conference Call Participants Dennis Geiger - UBS David Palmer - Evercore ISI Brian Bittner - Oppenheimer John Ivankoe - JPMorgan Gregory Francfort - Guggenheim Danilo Gargiulo - Bernstein Andrew Charles - TD Cowen Sara Senatore - Bank of America Jon Tower - Citi Christine Cho - Goldman Sachs Operator Good morning, and welcome to …

image for news Restaurant Brands International Inc. (QSR) Q1 2025 Earnings Call Transcript

Here's Why You Should Retain LKQ Stock in Your Portfolio Now — Positive

LKQ   Zacks Investment Research — May 08, 2025

LKQ is set to benefit from strategic acquisitions and a restructuring plan despite weak demand in the light vehicle and RV product lines.

image for news Here's Why You Should Retain LKQ Stock in Your Portfolio Now

MannKind Corporation (MNKD) Q1 2025 Earnings Call Transcript — Neutral

MNKD   Seeking Alpha — May 08, 2025

MannKind Corporation (NASDAQ:MNKD ) Q1 2025 Earnings Conference Call May 8, 2025 9:00 AM ET Company Participants Michael Castagna – Chief Executive Officer Chris Prentiss – Chief Financial Officer Conference Call Participants Olivia Brayer – Cantor Anish Nikhanj – RBC Andreas Argyrides – Oppenheimer & Co. Yun Zhong – Wedbush Anthony Petrone – Mizuho Operator Good morning, and welcome to the MannKind Corporation First Quarter 2025 Financial Results Earnings Call. As a reminder, this call is being recorded on May 08, 2025, and will be available for playback on the MannKind Corporation website shortly after the conclusion of this call …

image for news MannKind Corporation (MNKD) Q1 2025 Earnings Call Transcript

Americold Realty Trust, Inc. (COLD) Q1 2025 Earnings Call Transcript — Neutral

COLD   Seeking Alpha — May 08, 2025

Americold Realty Trust, Inc. (NYSE:COLD ) Q1 2025 Earnings Conference Call May 8, 2025 10:00 AM ET Company Participants Kevin Reed - Vice President, Investor Relations George Chappelle - Chief Executive Officer Rob Chambers - President, Americas Jay Wells - Chief Financial Officer Conference Call Participants Samir Khanal - Bank of America Steve Sakwa - Evercore ISI Greg McGinniss - Scotiabank Mike Mueller - JPMorgan Ki Bin Kim - Truist Securities Michael Carroll - RBC Nick Thillman - Baird Vince Tibone - Green Street Operator Greetings, and welcome to Americold Realty Trust First Quarter 2025 Earnings Call. At this time, …

image for news Americold Realty Trust, Inc. (COLD) Q1 2025 Earnings Call Transcript

Teva's betting big on biosimilars and specialty drugs, with AUSTEDO and UZEDY leading the charge. Management's $700 million cost-cutting plan is on track, aiming for a 30% operating margin by 2027. Recent FDA wins, like SELARSDI, show Teva's pushing into high-margin markets.

image for news Teva's Transformation: Why This 'Forgotten Pharma' Could Deliver 30% Upside

Coterra: 30%+ Upside Possible As Shares Hit Key Support — Positive

CTRA   Seeking Alpha — May 08, 2025

I have a buy rating on Coterra Energy (CTRA) due to its attractive valuation, trading at just seven times earnings with high free cash flow. Despite mixed quarterly results and strategic shifts, Coterra's impressive free cash flow generation and cost-saving measures make it a compelling investment. Key risks include weaker energy demand and potential internal negativity, but strong technical support around $22 suggests a decent chance of a bounce.

image for news Coterra: 30%+ Upside Possible As Shares Hit Key Support

Appian Corporation (APPN) Q1 2025 Earnings Call Transcript — Neutral

APPN   Seeking Alpha — May 08, 2025

Appian Corporation (NASDAQ:APPN ) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants Jack Andrews - Vice President of Investor Relations Matt Calkins - Founder and Chief Executive Officer Mark Lynch - Interim Chief Financial Officer Conference Call Participants Sanjit Singh - Morgan Stanley Raimo Lenschow - Barclays Steve Enders - Citi Jake Roberge - William Blair Nick Altmann - Scotiabank Devin Au - KeyBanc Capital Markets Operator Good day, and welcome to Appian's First Quarter 2025 Earnings Conference Call. All participants will be in the listen-only mode.

image for news Appian Corporation (APPN) Q1 2025 Earnings Call Transcript

MILWAUKEE , May 8, 2025 /PRNewswire/ -- Manpower®, a global leader in contingent staffing and permanent resourcing, and part of the ManpowerGroup (NYSE: MAN) family of brands, is proud to announce the expansion of its educational offerings, now including bachelor's degree programs in Nursing and Education through its MyPath Program. This initiative, in collaboration with the University of Phoenix, builds upon Manpower's existing Healthcare Management program and aims to provide accessible career advancement opportunities for healthcare professionals.

image for news Manpower Expands Educational Offerings with Nursing-Focused Degree, in Partnership with University of Phoenix, Paving the Path to Career Advancement for Healthcare Professionals

Jobless Claims, Q1 Productivity Hit Multi-Year Levels — Negative

COP  CROX  SHOP   Zacks Investment Research — May 08, 2025

Continuing Jobless Claims stayed above 1.9 million, and Productivity posted its first negative headline, in years.

image for news Jobless Claims, Q1 Productivity Hit Multi-Year Levels

Royalty Pharma (RPRX) Reports Q1 Earnings: What Key Metrics Have to Say — Neutral

RPRX   Zacks Investment Research — May 08, 2025

While the top- and bottom-line numbers for Royalty Pharma (RPRX) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

image for news Royalty Pharma (RPRX) Reports Q1 Earnings: What Key Metrics Have to Say

Palantir's Q1 earnings sparkled, but the guidance was below expectations. For an expensive growth stock, no room for disappointment. PLTR investors who bought at the recent highs could be in for a reckoning. This week's selloff may not be over yet. Palantir's evolution into the preeminent AI platform company has credence and is validated. However, its valuation has arguably reached unreasonable levels.

image for news Palantir: The Warning Sign You Must Not Ignore Any Longer (Rating Downgrade)

The company missed first-quarter revenue estimates and posted a larger-than-expected loss due to a sluggish box office performance and ongoing declines in cable.

image for news Warner Bros. Discovery shares climb as CNN parent weighs splitting company: report